BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22349684)

  • 1. A possible role for CSF turnover and choroid plexus in the pathogenesis of late onset Alzheimer's disease.
    Serot JM; Zmudka J; Jouanny P
    J Alzheimers Dis; 2012; 30(1):17-26. PubMed ID: 22349684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human choroid plexus growth factors: What are the implications for CSF dynamics in Alzheimer's disease?
    Stopa EG; Berzin TM; Kim S; Song P; Kuo-LeBlanc V; Rodriguez-Wolf M; Baird A; Johanson CE
    Exp Neurol; 2001 Jan; 167(1):40-7. PubMed ID: 11161591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal Fluid from Alzheimer's disease patients promotes amyloid beta-protein oligomerization.
    Ikeda T; Ono K; Elashoff D; Condron MM; Noguchi-Shinohara M; Yoshita M; Teplow DB; Yamada M
    J Alzheimers Dis; 2010; 21(1):81-6. PubMed ID: 20413863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.
    Tapiola T; Alafuzoff I; Herukka SK; Parkkinen L; Hartikainen P; Soininen H; Pirttilä T
    Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligomerization partially explains the lowering of Abeta42 in Alzheimer's disease cerebrospinal fluid.
    Englund H; Degerman Gunnarsson M; Brundin RM; Hedlund M; Kilander L; Lannfelt L; Pettersson FE
    Neurodegener Dis; 2009; 6(4):139-47. PubMed ID: 19521063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.
    Fagan AM; Mintun MA; Mach RH; Lee SY; Dence CS; Shah AR; LaRossa GN; Spinner ML; Klunk WE; Mathis CA; DeKosky ST; Morris JC; Holtzman DM
    Ann Neurol; 2006 Mar; 59(3):512-9. PubMed ID: 16372280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genes involved in cerebrospinal fluid production as candidate genes for late-onset Alzheimer's disease: a hypothesis.
    Wostyn P; van Dam D; Audenaert K; de Deyn PP
    J Neurogenet; 2011 Dec; 25(4):195-200. PubMed ID: 22023247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings.
    Seppälä TT; Nerg O; Koivisto AM; Rummukainen J; Puli L; Zetterberg H; Pyykkö OT; Helisalmi S; Alafuzoff I; Hiltunen M; Jääskeläinen JE; Rinne J; Soininen H; Leinonen V; Herukka SK
    Neurology; 2012 May; 78(20):1568-75. PubMed ID: 22517093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystatin C levels are positively correlated with both Abeta42 and tau levels in cerebrospinal fluid in persons with Alzheimer's disease, mild cognitive impairment, and healthy controls.
    Sundelöf J; Sundström J; Hansson O; Eriksdotter-Jönhagen M; Giedraitis V; Larsson A; Degerman-Gunnarsson M; Ingelsson M; Minthon L; Blennow K; Kilander L; Basun H; Lannfelt L
    J Alzheimers Dis; 2010; 21(2):471-8. PubMed ID: 20555147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
    Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid profile of amyloid β42 (Aβ42), hTau and ubiquitin in North Indian Alzheimer's disease patients.
    Kandimalla RJ; S P; Bk B; Wani WY; Sharma DR; Grover VK; Bhardwaj N; Jain K; Gill KD
    Neurosci Lett; 2011 Jan; 487(2):134-8. PubMed ID: 20599474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid-β peptide(1-40) elimination from cerebrospinal fluid involves low-density lipoprotein receptor-related protein 1 at the blood-cerebrospinal fluid barrier.
    Fujiyoshi M; Tachikawa M; Ohtsuki S; Ito S; Uchida Y; Akanuma S; Kamiie J; Hashimoto T; Hosoya K; Iwatsubo T; Terasaki T
    J Neurochem; 2011 Aug; 118(3):407-15. PubMed ID: 21585370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairments in brain-to-blood transport of amyloid-β and reabsorption of cerebrospinal fluid in an animal model of Alzheimer's disease are reversed by antisense directed against amyloid-β protein precursor.
    Banks WA; Kumar VB; Farr SA; Nakaoke R; Robinson SM; Morley JE
    J Alzheimers Dis; 2011; 23(4):599-605. PubMed ID: 21098986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptors alpha and beta in choroid plexus epithelial cells in Alzheimer's disease.
    Hong-Goka BC; Chang FL
    Neurosci Lett; 2004 Apr; 360(3):113-6. PubMed ID: 15082146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.
    Hansson O; Zetterberg H; Buchhave P; Andreasson U; Londos E; Minthon L; Blennow K
    Dement Geriatr Cogn Disord; 2007; 23(5):316-20. PubMed ID: 17374949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased CSF-BACE1 activity associated with decreased hippocampus volume in Alzheimer's disease.
    Ewers M; Cheng X; Zhong Z; Nural HF; Walsh C; Meindl T; Teipel SJ; Buerger K; He P; Shen Y; Hampel H
    J Alzheimers Dis; 2011; 25(2):373-81. PubMed ID: 21460439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation of β-amyloid from lipoprotein in cerebrospinal fluid from Alzheimer's disease accelerates β-amyloid-42 assembly.
    Takamura A; Kawarabayashi T; Yokoseki T; Shibata M; Morishima-Kawashima M; Saito Y; Murayama S; Ihara Y; Abe K; Shoji M; Michikawa M; Matsubara E
    J Neurosci Res; 2011 Jun; 89(6):815-21. PubMed ID: 21394760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteic acid induces intraneuronal accumulation of neurotoxic Abeta42: implications for the pathogenesis of Alzheimer's disease.
    Hasegawa T; Ukai W; Jo DG; Xu X; Mattson MP; Nakagawa M; Araki W; Saito T; Yamada T
    J Neurosci Res; 2005 Jun; 80(6):869-76. PubMed ID: 15898106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of CSF markers in the early diagnosis of Alzheimer's disease].
    Vos SJ; Visser PJ; Verhey FR
    Tijdschr Psychiatr; 2011; 53(9):647-53. PubMed ID: 21898322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ageing choroid plexus-cerebrospinal fluid system.
    Preston JE
    Microsc Res Tech; 2001 Jan; 52(1):31-7. PubMed ID: 11135446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.